These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15476236)

  • 1. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
    Janssen R; Verhard E; Lankester A; Ten Cate R; van Dissel JT
    Arthritis Rheum; 2004 Oct; 50(10):3329-33. PubMed ID: 15476236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
    Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T
    Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1.
    Frenkel J; van Kempen MJ; Kuis W; van Amstel HK
    Arthritis Rheum; 2004 Aug; 50(8):2719-20. PubMed ID: 15334500
    [No Abstract]   [Full Text] [Related]  

  • 5. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.
    Feldmann J; Prieur AM; Quartier P; Berquin P; Certain S; Cortis E; Teillac-Hamel D; Fischer A; de Saint Basile G
    Am J Hum Genet; 2002 Jul; 71(1):198-203. PubMed ID: 12032915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
    Aksentijevich I; Putnam CD; Remmers EF; Mueller JL; Le J; Kolodner RD; Moak Z; Chuang M; Austin F; Goldbach-Mansky R; Hoffman HM; Kastner DL
    Arthritis Rheum; 2007 Apr; 56(4):1273-1285. PubMed ID: 17393462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
    Ting TV; Scalzi LV; Hashkes PJ
    Pediatr Neurol; 2007 May; 36(5):338-41. PubMed ID: 17509468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CINCA Syndrome.
    Khemani C; Khubchandani R
    Indian Pediatr; 2007 Dec; 44(12):933-6. PubMed ID: 18175851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exacerbation of skin lesions during fever in a patient with chronic infantile neurologic cutaneous articular (CINCA) syndrome].
    Aboín-González S; Aldanondo-Fernández de la Mora I; García-Acebes CR; Carrillo-Gijón R; Harto-Castaño A; Jaén-Olasolo P
    Actas Dermosifiliogr; 2008; 99(6):481-4. PubMed ID: 18558058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.
    Neven B; Callebaut I; Prieur AM; Feldmann J; Bodemer C; Lepore L; Derfalvi B; Benjaponpitak S; Vesely R; Sauvain MJ; Oertle S; Allen R; Morgan G; Borkhardt A; Hill C; Gardner-Medwin J; Fischer A; de Saint Basile G
    Blood; 2004 Apr; 103(7):2809-15. PubMed ID: 14630794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents.
    Matsubara T; Hasegawa M; Shiraishi M; Hoffman HM; Ichiyama T; Tanaka T; Ueda H; Ishihara T; Furukawa S
    Arthritis Rheum; 2006 Jul; 54(7):2314-20. PubMed ID: 16802372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.
    Kanneganti TD; Ozören N; Body-Malapel M; Amer A; Park JH; Franchi L; Whitfield J; Barchet W; Colonna M; Vandenabeele P; Bertin J; Coyle A; Grant EP; Akira S; Núñez G
    Nature; 2006 Mar; 440(7081):233-6. PubMed ID: 16407888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome.
    Hentgen V; Despert V; Leprêtre AC; Cuisset L; Chevrant-Breton J; Jégo P; Chalès G; Gall EL; Delpech M; Grateau G
    J Rheumatol; 2005 Apr; 32(4):747-51. PubMed ID: 15801036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
    Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
    Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.